Meningitis B jab to be added to NHS child vaccine schedule

Behind the Headlines

Monday March 30 2015

The jab can be given to infants from the age of two months

"All babies in the UK will soon have a potentially life-saving vaccine against meningitis B," The Guardian reports. The vaccine, Bexsero, will soon be offered to babies once they reach the age of two months, followed by two more booster shots.

 

What is meningitis B?

Meningitis B is a highly aggressive strain of bacterial meningitis that infects the protective membranes surrounding the brain and spinal cord. It is very serious and should be treated as a medical emergency. If the infection is left untreated, it can cause severe brain damage and infect the blood (septicaemia). In some cases, bacterial meningitis can be fatal.

 

How common is meningitis B?

The charity Meningitis Now estimates that there are 1,870 cases of meningitis B each year in the UK. Meningitis B is most common in children under five years old, particularly in babies under the age of one.

Initial signs and symptoms of meningitis B in babies include:

  • a high temperature with cold hands and feet
  • they may feel agitated, but not want to be touched
  • they may cry continuously
  • some children are very sleepy and it may be difficult to wake them up
  • they may appear confused and unresponsive
  • they may develop a blotchy red rash that does not fade when you roll a glass over it

For more information, read about the signs and symptoms of serious illness in babies.

 

Why is this meningitis B vaccine in the news?

The development of a safe and effective meningitis B vaccine is the culmination of more than 20 years of research and represents a significant breakthrough in disease prevention.

 

What do we know about the vaccine?

The vaccine, Bexsero, is thought to provide 73% protection against meningitis B, which should significantly reduce the number of cases. The vaccine can be administered to infants aged two months or older either by itself, or in combination with other childhood vaccines.

The vaccine has been tested in clinical trials involving more than 8,000 people.

In infants, it was found to have similar levels of safety and tolerability as other routine childhood vaccines. The most commonly reported side effects were:

  • redness and swelling at the site of the injection
  • irritability
  • fever

It is thought that the vaccine will become available on the NHS in the autumn.

 

Edited by NHS Choices. Follow Behind the Headlines on Twitter.

Edited by NHS Choices

Ratings

How helpful is this page?

Average rating

Based on 6 ratings

All ratings

3  ratings
2  ratings
0  ratings
0  ratings
1  ratings

Add your rating

Meningitis real story

Tracey Chambers talks about the effects of meningitis on her daughter Courteney. Meningitis is an infection that can lead to serious damage to the nerves and brain. If you think your child has symptoms of meningitis, it is vital to seek immediate medical attention.

Media last reviewed: 08/07/2015

Next review due: 08/07/2017

What is Behind the Headlines?

What is Behind the Headlines?

We give you the facts without the fiction. Professor Sir Muir Gray, founder of Behind the Headlines, explains more...

Men B vaccine

A new Men B vaccine called Bexsero is available on the NHS for babies aged 8 weeks, 16 weeks and one year old

Meningitis Symptom Alert

Learn to recognise meningitis

This symptom alert shows the signs and includes a printable checklist